Trulieve Receives DEA Medical Marijuana Registrations

Trulieve Cannabis Corp. is among the first state-licensed medical marijuana operators to gain federal DEA registration under a new framework.

Updated on Nov. 2, 2026 in Gambling

Bold flat-color editorial illustration of a single cannabis bud beside a tiered stack of cream blocks on a slate surface, in deep green and cream. — The Drug Enforcement Administration on Friday began issuing federal registrations to qualifying state-licensed medical marijuana operators, with Trulieve Cannabis Corp. among the first to receive one. AI Illustration. Upload story photo >

Live Poll

Do you support making medical marijuana easier for patients to access nationwide?

Trulieve Cannabis Corp. received DEA registrations for certain retail facilities as the agency began initial issuance of federal registrations to qualifying state-licensed medical marijuana dispensaries. The DEA announced the initial issuance on Friday, October 30, as the first phase of an April order by the Attorney General.

Why it matters

The federal framework maintains controls under the Controlled Substances Act while establishing a pathway for qualifying medical marijuana businesses to operate under federal oversight. Trulieve's CEO said the federal reclassification of state-licensed medical marijuana opens the door for clinical research.

The DEA's initial issuance is the first phase of an April Attorney General order that reclassified state-licensed medical marijuana to Schedule III under the Controlled Substances Act. Total registrations issued and remaining phases were not disclosed in the source material.

The players

Trulieve Cannabis Corp.

Trulieve is a medical cannabis company that operates state-licensed dispensaries and is among the first to receive federal DEA registration under the new framework.

Drug Enforcement Administration (DEA)

The DEA is the federal agency responsible for enforcing the Controlled Substances Act and issuing registrations to businesses handling controlled substances.

The details

Trulieve applied for DEA registration for its state-licensed operations in April, and the DEA began issuing registrations on October 30, 2026. Trulieve announced receipt of its registrations on November 2, 2026, with the framework expected to continue under ongoing DEA engagement.

April 2026: Attorney General order issued, and Trulieve applied for DEA registration.
October 30, 2026: DEA announced initial issuance of federal registrations.
November 2, 2026: Trulieve announced receipt of DEA registrations.

Big Picture

The federal reclassification of state-licensed medical marijuana to Schedule III under the Controlled Substances Act marks a departure from its prior Schedule I status. The DEA registration pathway places qualifying operators within existing federal controls rather than outside them.

Consumers of state-licensed medical marijuana may see changes in how dispensaries operate under federal oversight, though the source material does not specify changes to pricing or availability. Federal reclassification is described as opening the door for clinical research, which may affect future product development over time.

The takeaway

Federal registration does not remove the Controlled Substances Act controls that still apply to medical marijuana businesses. Readers tracking the industry should watch for later DEA issuance phases and the research opportunities that federal reclassification may create.